USPTO serial 97735383
WUXI VACCINES
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Apr 23, 2024
- Examiner
- WATTS-FITZGERALD, CAITLIN C
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with WUXI VACCINES?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Eric Lamb
Eric Lamb FROST BROWN TODD LLP201 NORTH ILLINOIS STREETSUITE 1900INDIANAPOLIS, IN 46204Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 040 | Custom assembling of materials for others, being custom manufacture of pharmaceuticals, chemotherapy drugs, antibiotic medicines, and vaccines by pharmaceutical compounders; Custom manufacture of medical preparations in the nature of pharmaceuticals; Customized biomanufacturing of pharmaceuticals; Custom manufacture of vaccines for preventing or treating infectious diseases, cancer and allergies or autoimmunity; Material processing being processing of medicinal plants and manufacturing of pharmaceuticals using biological organisms in the manufacturing process, all in the medicinal field; Processing of drugs, being biomanufacturing for others in the nature of custom manufacturing of pharmaceuticals; Processing of biomedical preparations, namely, biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; Processing of vaccines, being custom manufacture of vaccines for preventing or treating infectious diseases, cancer and allergies or autoimmunity | ACTIVE | — |
| 042 | Developing new products for others; Development of medicines; Scientific research and development; Pharmaceutical research; Research and development of new products; Consulting services in the field of development of new technology for others; Biochemical research and analysis; Biomedical research; Development of pharmaceutical preparations and pharmaceutical drugs; Research and development of pharmaceutical drugs; Custom design and development of chemical reagents for scientific or medical research use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 23, 2024 | NRCS | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Apr 23, 2024 | R.SR | REGISTERED-SUPPLEMENTAL REGISTER | Your mark is registered on the Supplemental Register, which is available for marks that are not yet distinctive enough for the Principal Register but can still identify a source. Protection is more limited than Principal Register registration but can later support a Principal Register application. |
| Mar 8, 2024 | ERRR | ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED | — |
| Mar 4, 2024 | CNTA | APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER | — |
| Mar 4, 2024 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 4, 2024 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2024 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 4, 2024 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Dec 4, 2023 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Dec 4, 2023 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Dec 4, 2023 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Nov 30, 2023 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Nov 30, 2023 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Nov 30, 2023 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2023 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2023 | GNRT | NON-FINAL ACTION E-MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 27, 2023 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 26, 2023 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 24, 2023 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jan 2, 2023 | NWAP | NEW APPLICATION ENTERED | — |